These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 19335070)
21. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Hie M; Iitsuka N; Otsuka T; Tsukamoto I Int J Mol Med; 2011 Sep; 28(3):455-62. PubMed ID: 21567076 [TBL] [Abstract][Full Text] [Related]
22. Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism. Endo Y; Beauchamp E; Woods D; Taylor WG; Toretsky JA; Uren A; Rubin JS Mol Cell Biol; 2008 Apr; 28(7):2368-79. PubMed ID: 18212053 [TBL] [Abstract][Full Text] [Related]
23. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. Li X; Zhang Y; Kang H; Liu W; Liu P; Zhang J; Harris SE; Wu D J Biol Chem; 2005 May; 280(20):19883-7. PubMed ID: 15778503 [TBL] [Abstract][Full Text] [Related]
24. The role of Wnt signaling and sclerostin in the pathogenesis of glucocorticoid-induced osteoporosis. Guañabens N; Gifre L; Peris P Curr Osteoporos Rep; 2014 Mar; 12(1):90-7. PubMed ID: 24488619 [TBL] [Abstract][Full Text] [Related]
25. WNTs in the ovine uterus: potential regulation of periimplantation ovine conceptus development. Hayashi K; Burghardt RC; Bazer FW; Spencer TE Endocrinology; 2007 Jul; 148(7):3496-506. PubMed ID: 17431004 [TBL] [Abstract][Full Text] [Related]
26. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo. Kulkarni NH; Onyia JE; Zeng Q; Tian X; Liu M; Halladay DL; Frolik CA; Engler T; Wei T; Kriauciunas A; Martin TJ; Sato M; Bryant HU; Ma YL J Bone Miner Res; 2006 Jun; 21(6):910-20. PubMed ID: 16753022 [TBL] [Abstract][Full Text] [Related]
27. Hematopoietic stem cell fate decisions are regulated by Wnt antagonists: comparisons and current controversies. Cain CJ; Manilay JO Exp Hematol; 2013 Jan; 41(1):3-16. PubMed ID: 23022129 [TBL] [Abstract][Full Text] [Related]
28. Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. Choi HY; Dieckmann M; Herz J; Niemeier A PLoS One; 2009 Nov; 4(11):e7930. PubMed ID: 19936252 [TBL] [Abstract][Full Text] [Related]
29. Influence of Calcium Supplementation against Fluoride-Mediated Osteoblast Impairment in Vitro: Involvement of the Canonical Wnt/β-Catenin Signaling Pathway. Wang J; Yang J; Cheng X; Yin F; Zhao Y; Zhu Y; Yan Z; Khodaei F; Ommati MM; Manthari RK; Wang J J Agric Food Chem; 2019 Sep; 67(37):10285-10295. PubMed ID: 31443611 [TBL] [Abstract][Full Text] [Related]
30. Fluoride promotes osteoblastic differentiation through canonical Wnt/β-catenin signaling pathway. Pan L; Shi X; Liu S; Guo X; Zhao M; Cai R; Sun G Toxicol Lett; 2014 Feb; 225(1):34-42. PubMed ID: 24300170 [TBL] [Abstract][Full Text] [Related]
32. An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts. Rybchyn MS; Slater M; Conigrave AD; Mason RS J Biol Chem; 2011 Jul; 286(27):23771-9. PubMed ID: 21566129 [TBL] [Abstract][Full Text] [Related]
33. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Glass DA; Bialek P; Ahn JD; Starbuck M; Patel MS; Clevers H; Taketo MM; Long F; McMahon AP; Lang RA; Karsenty G Dev Cell; 2005 May; 8(5):751-64. PubMed ID: 15866165 [TBL] [Abstract][Full Text] [Related]
34. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells. Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355 [TBL] [Abstract][Full Text] [Related]
35. Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders. Marini F; Giusti F; Palmini G; Brandi ML Osteoporos Int; 2023 Feb; 34(2):213-238. PubMed ID: 35982318 [TBL] [Abstract][Full Text] [Related]
36. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy. van de Schans VA; van den Borne SW; Strzelecka AE; Janssen BJ; van der Velden JL; Langen RC; Wynshaw-Boris A; Smits JF; Blankesteijn WM Hypertension; 2007 Mar; 49(3):473-80. PubMed ID: 17210832 [TBL] [Abstract][Full Text] [Related]
37. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. Kansara M; Tsang M; Kodjabachian L; Sims NA; Trivett MK; Ehrich M; Dobrovic A; Slavin J; Choong PF; Simmons PJ; Dawid IB; Thomas DM J Clin Invest; 2009 Apr; 119(4):837-51. PubMed ID: 19307728 [TBL] [Abstract][Full Text] [Related]
38. Wnt signaling in osteosarcoma. Lin CH; Ji T; Chen CF; Hoang BH Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167 [TBL] [Abstract][Full Text] [Related]
39. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. Chen Y; Whetstone HC; Lin AC; Nadesan P; Wei Q; Poon R; Alman BA PLoS Med; 2007 Jul; 4(7):e249. PubMed ID: 17676991 [TBL] [Abstract][Full Text] [Related]
40. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders. Levasseur R; Lacombe D; de Vernejoul MC Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]